Senseonics Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SENS and other ETFs, options, and stocks.

About SENS

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. 

CEO
Timothy T. Goodnow
CEOTimothy T. Goodnow
Employees
117
Employees117
Headquarters
Germantown, Maryland
HeadquartersGermantown, Maryland
Founded
2014
Founded2014
Employees
117
Employees117

SENS Key Statistics

Market cap
282.72M
Market cap282.72M
Price-Earnings ratio
-4.18
Price-Earnings ratio-4.18
Dividend yield
Dividend yield
Average volume
493.53K
Average volume493.53K
High today
$7.25
High today$7.25
Low today
$6.90
Low today$6.90
Open price
$7.08
Open price$7.08
Volume
71.27K
Volume71.27K
52 Week high
$28.00
52 Week high$28.00
52 Week low
$5.25
52 Week low$5.25

Stock Snapshot

As of today, Senseonics Holdings(SENS) shares are valued at $6.90. The company's market cap stands at 282.72M, with a P/E ratio of -4.18.

During the trading session on 2026-01-14, Senseonics Holdings(SENS) shares reached a daily high of $7.25 and a low of $6.90. At a current price of $6.90, the stock is 0.0% higher than the low and still -4.8% under the high.

Trading activity shows a volume of 71.27K, compared to an average daily volume of 493.53K.

Over the past 52 weeks, Senseonics Holdings(SENS) stock has traded between a high of $28.00 and a low of $5.25.

Over the past 52 weeks, Senseonics Holdings(SENS) stock has traded between a high of $28.00 and a low of $5.25.

SENS News

TipRanks 2d
Senseonics Reports Record 2025 Revenue and Growth Milestones

Claim 70% Off TipRanks Premium Senseonics Holdings ( (SENS) ) has issued an update. On January 12, 2026, Senseonics reported preliminary unaudited revenue of...

TipRanks 6d
Senseonics reports first commercial patients using Eversense 365 CGM with twiist

Senseonics (SENS) with Sequel MedTech have launched the integration of their products with the first patients having received a Sequel twiist AID system paired...

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
25%
Sell
12.5%

People also own

Based on the portfolios of people who own SENS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .